Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine interaction study with atazanavir/ritonavir with or without tenofovir in HIV-infected subjects
2006-003163-31Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of famotidine, atazanavir, ritonavir and tenofovir in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Bristol Myers Squibb. Primary endpoints: Pharmacokinetic measures and Ritonavir pharmacokinetics. Started Oct 2006; status: completed.
02
Drugs
famotidineatazanavirritonavirtenofovir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-003163-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003163-31.